INTRODUCTION: Androgenetic alopecia (AGA) is the most common type of hair loss. Platelet-rich plasma (PRP) and mesotherapy (MZT) injections of various solutions fortified with growth factors are popular treatment options for AGA. The aim of this study was to compare the efficacy of RPP and MZT products in the treatment of AGA. METHODS: This retrospective study included 72 AGA patients treated with two PRP formulations and two MZT products, administered manually or with a gun injector. Hair parameters (hair thickness, hair density, and hair count) on frontal and vertex areas were measured before and after 6 months. RESULTS: Over 6 months, trichoscopic parameters showed significant intragroup and intergroup variability. MZT1 and PRP2 groups exhibited statistically significant improvement in most parameters, while MZT2 significantly increased vertex hair density. Hair thickness changes differed significantly between PRP1 and PRP2 groups (unadjusted p value <0.001) and possibly between MZT1 and PRP1 groups (unadjusted p value = 0.049) in both regions. DISCUSSION: Injections of PRP and MZT formulations can significantly enhance trichoscopic parameters in AGA patients within a 6-month period, but the extent of improvement varies among different PRP and MZT products.

Department of Dermatovenerology 3rd Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady Prague Czech Republic

Department of Dermatovenerology EKPA University Athens Greece

Zobrazit více v PubMed

Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. . Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018;32(1):11–22. PubMed

Mao Y, Liu P, Wei J, Xie Y, Zheng Q, Li R, et al. . Cell therapy for androgenetic alopecia: elixir or trick? Stem Cell Rev Rep. 2023;19(6):1785–99. PubMed PMC

Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord. 2018;4(1):18–24. PubMed PMC

Stefanis AJ, Groh T, Arenbergerova M, Arenberger P, Bauer PO. Stromal vascular fraction and its role in the management of alopecia: a review. J Clin Aesthet Dermatol. 2019;12(11):35–44. PubMed PMC

Evans AG, Mwangi JM, Pope RW, Ivanic MG, Botros MA, Glassman GE, et al. . Platelet-rich plasma as a therapy for androgenic alopecia: a systematic review and meta-analysis. J Dermatolog Treat. 2020;33:498–511. PubMed

Plachouri KM, Georgiou S. Mesotherapy: safety profile and management of complications. J Cosmet Dermatol. 2019;18(6):1601–5. PubMed

Gajjar PC, Mehta HH, Barvaliya M, Sonagra B. Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: a randomized controlled trial. Int J Trichology. 2019;11(2):58–67. PubMed PMC

Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359–65. PubMed

Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97(3):247–54. PubMed

Bishop YM, Fienberg SE, Holland PW. Discrete multivariate analysis. In: Theory and practice. New York: Springer; 2007.

Li M, Qu K, Lei Q, Chen M, Bian D. Effectiveness of platelet-rich plasma in the treatment of androgenic alopecia: a meta-analysis. Aesthetic Plast Surg. 2024;48(5):977–84. PubMed PMC

Zhang X, Ji Y, Zhou M, Zhou X, Xie Y, Zeng X, et al. . Platelet-rich plasma for androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials. J Cutan Med Surg. 2023;27(5):504–8. PubMed

Gupta AK, Carviel JL. Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia. J Dermatolog Treat. 2017;28(1):55–8. PubMed

Paichitrojjana A, Paichitrojjana A. Platelet rich plasma and its use in hair regrowth: a review. Drug Des Devel Ther. 2022;16:635–45. PubMed PMC

Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg. 2014;7(4):189–97. PubMed PMC

Ince B. Response to comparison of the efficacy of homologous and autologous Platelet-Rich Plasma (PRP) for treating androgenic alopecia. Aesthetic Plast Surg. 2023. PubMed

Fukuoka H, Suga H, Narita K, Watanabe R, Shintani S. The latest advance in hair regeneration therapy using proteins secreted by adipose-derived stem cells. Am J Cosmet Surg. 2012;29(4):273–82.

Fukuoka H, Suga H. Hair regeneration treatment using adipose-derived stem cell conditioned medium: follow-up with trichograms. Eplasty. 2015;15:e10. PubMed PMC

Kapoor R, Shome D. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study. J Cosmet Laser Ther. 2018;20(6):369–79. PubMed

Kim S, Kye J, Lee M, Park B. Evaluation of mesotherapy as a transdermal drug delivery tool. Skin Res Technol. 2016;22(2):158–63. PubMed

Li C, Pan L, Yang L, Kong J, Zhang L. An umbrella review of the use of platelet-rich plasma in the treatment of androgenetic alopecia. J Cosmet Dermatol. 2023;22(5):1463–76. PubMed